Tecon Biology Co (SZSE:002100) Debt-to-Equity : 1.07 (As of Mar. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Tecon Biology Co Debt-to-Equity?

Tecon Biology Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥4,888 Mil. Tecon Biology Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥1,970 Mil. Tecon Biology Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥6,412 Mil. Tecon Biology Co's debt to equity for the quarter that ended in Mar. 2024 was 1.07.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Tecon Biology Co's Debt-to-Equity or its related term are showing as below:

SZSE:002100' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.16 Med: 0.78 Max: 1.45
Current: 1.07

During the past 13 years, the highest Debt-to-Equity Ratio of Tecon Biology Co was 1.45. The lowest was 0.16. And the median was 0.78.

SZSE:002100's Debt-to-Equity is ranked worse than
79.85% of 1648 companies
in the Consumer Packaged Goods industry
Industry Median: 0.41 vs SZSE:002100: 1.07

Tecon Biology Co Debt-to-Equity Historical Data

The historical data trend for Tecon Biology Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tecon Biology Co Debt-to-Equity Chart

Tecon Biology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

1.02

1.06

1.00

0.93

1.00

Tecon Biology Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															1.01	0.98	0.78	1.00	1.07

Competitive Comparison of Tecon Biology Co's Debt-to-Equity

For the Packaged Foods subindustry, Tecon Biology Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tecon Biology Co's Debt-to-Equity Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Tecon Biology Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Tecon Biology Co's Debt-to-Equity falls into.

Tecon Biology Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Tecon Biology Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(4807.791	+	1588.288)	/	6410.601
	=	1.00

Tecon Biology Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(4887.565	+	1969.516)	/	6411.813
	=	1.07

Tecon Biology Co (SZSE:002100) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Tecon Biology Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Tecon Biology Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Tecon Biology Co (SZSE:002100) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Tecon Biology Co Ltd (SZSE:002100) » Definitions » Debt-to-Equity

Traded in Other Exchanges

N/A

Address

High-tech Zone in Changchun Road, 528 Tiankang Business Building, Xinjiang, Urumqi, CHN, 830011

Website

http://www.tcsw.com.cn

Tecon Biology Co Ltd is engaged in the production and sales of veterinary biological products and animal disease prevention, modern pig science breeding and breeding, feed research and development and production, and pig slaughtering and processing. The company mainly operates its businesses within domestic markets, with Xinjiang Province as its main market.

Tecon Biology Co (SZSE:002100) Headlines

No Headlines